Inventor · disambiguated record
Eric Q. Parkhill
Also filed as: PARKHILL ERIC · PARKHILL ERIC Q
27 granted patents·10 pending applications·188 citations·filing 2007–2025
96Inventor score
Files withGILEAD SCIENCES INC20GILEAD PALO ALTO INC6CORKEY BRITTON KENNETH3KOLTUN DMITRY3CORKEY BRITTON2
Top patents by PatentIndex Score
37 records- 0196US11179397B2Imidazopyrimidine derivativesGILEAD SCIENCES INC·Filed 2019·Granted Nov 23, 2021·23 cites·13 claims
- 0294US9371329B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON·Filed 2014·Granted Jun 21, 2016·26 cites·2 claims
- 0394US8952034B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON·Filed 2010·Granted Feb 10, 2015·29 cites·18 claims
- 0494US8586732B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON KENNETH·Filed 2012·Granted Nov 19, 2013·29 cites·35 claims
- 0591US10710986B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Jul 14, 2020·4 cites·5 claims
- 0691US9676760B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2016·Granted Jun 13, 2017·7 cites·2 claims
- 0791US9598435B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2015·Granted Mar 21, 2017·9 cites·13 claims
- 0890US9193694B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2013·Granted Nov 24, 2015·11 cites·11 claims
- 0987US7662819B2Pteridinone derivatives for use as stearoyl CoA desaturase inhibitorsGILEAD PALO ALTO INC·Filed 2007·Granted Feb 16, 2010·15 cites·17 claims
- 1084US9403782B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2015·Granted Aug 2, 2016·4 cites·10 claims
- 1183US11555029B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2020·Granted Jan 17, 2023·1 cites·9 claims
- 1283US8703759B2Fused heterocyclic compounds as ion channel modulatorsKOBAYASHI TETSUYA·Filed 2011·Granted Apr 22, 2014·7 cites·25 claims
- 1382US11040033B2Therapeutic heterocyclic compoundsGILEAD SCIENCES INC·Filed 2018·Granted Jun 22, 2021·1 cites·22 claims
- 1482US9079901B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2014·Granted Jul 14, 2015·5 cites·24 claims
- 1582US8962610B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON KENNETH·Filed 2012·Granted Feb 24, 2015·6 cites·21 claims
- 1681US9115096B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON KENNETH·Filed 2012·Granted Aug 25, 2015·5 cites·13 claims
- 1781US7893066B2Pyridol[2,3-B]pyrazinones for use as stearoyl CoA desaturase inhibitorsGILEAD PALO ALTO INC·Filed 2008·Granted Feb 22, 2011·5 cites·22 claims
- 1878US2025270195A1Pd-1/pd-l1 inhibitorsGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
- 1977US12338233B2PD-1/Pd-L1 inhibitorsGILEAD SCIENCES INC·Filed 2022·Granted Jun 24, 2025·0 cites·4 claims
- 2072US2010113461A1Substituted heterocyclic compoundsGILEAD PALO ALTO INC·Filed 2009·Application pending·0 cites
- 2169US7732453B2Pyrido[2,3-B] pyrazin-3(4H)-ones for use as stearoyl CoA desaturase inhibitorsGILEAD PALO ALTO INC·Filed 2007·Granted Jun 8, 2010·1 cites·21 claims
- 2265US2022241281A1Imidazopyrimidine DerivativesGILEAD SCIENCES INC·Filed 2021·Application pending·0 cites
- 2363US11229638B2Therapeutic heterocyclic compoundsGILEAD SCIENCES INC·Filed 2018·Granted Jan 25, 2022·0 cites·7 claims
- 2451US9682998B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2016·Granted Jun 20, 2017·0 cites·12 claims
- 2551US8912190B2Substituted heterocyclic compoundsGILEAD SCIENCES INC·Filed 2012·Granted Dec 16, 2014·0 cites·7 claims
- 2649US2010267752A13-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORSGILEAD PALO ALTO INC·Filed 2009·Application pending·0 cites
- 2748US2018305315A1Pd-1/pd-l1 inhibitorsGILEAD SCIENCES INC·Filed 2018·Application pending·0 cites
- 2847US10899735B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Jan 26, 2021·0 cites·9 claims
- 2947US2007208040A1A2a adenosine receptor antagonistsELZEIN ELFATIH·Filed 2007·Application pending·0 cites
- 3046US11236085B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Feb 1, 2022·0 cites·28 claims
- 3146US2009253704A1PYRROLOTRIAZINONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORSKOLTUN DMITRY·Filed 2009·Application pending·0 cites
- 3243US2009105283A13-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORSKOLTUN DMITRY·Filed 2008·Application pending·0 cites
- 3342US10100058B2Fused heterocyclic compounds as CaM kinase inhibitorsGILEAD SCIENCES INC·Filed 2017·Granted Oct 16, 2018·0 cites·33 claims
- 3442US9695192B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2015·Granted Jul 4, 2017·0 cites·7 claims
- 3539US2008255161A13-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORSKOLTUN DMITRY·Filed 2008·Application pending·0 cites
- 3639US2010113463A1PTERIDINONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORSGILEAD PALO ALTO INC·Filed 2010·Application pending·0 cites
- 3735US8148376B23, 4-dihydroquinoxalin-2(1H)-ones for use as stearoyl CoA desaturase inhibitorsCHISHOLM JEFFREY·Filed 2010·Granted Apr 3, 2012·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Eric Q. Parkhill files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →